A novel point mutation (I137T) in the conserved 5-phosphoribosyl-1-pyrophosphate binding motif of hypoxanthine-guanine phosphoribosyltransferase (HPRTJerusalem) in a variant of Lesch-Nyhan syndrome

Esther Zoref-Shani*, Yael Bromberg, Joel Hirsch, Sofia Feinstein, Yaacov Frishberg, Oded Sperling

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

We identified a novel point mutation (I137T) in the hypoxanthine-guanine phosphoribosyltransferase (HPRT; EC 2.4.2.8) encoding gene, in a patient with partial deficiency of the enzyme (variant of Lesch-Nyhan syndrome). The mutation, ATT to ACT, resulting in substitution of isoleucine to threonine, occurred at codon 137 (exon 6), which is within the region encoding the binding site for 5-phosphoribosyl-1-pyrophosphate (PRPP). We suggest the mechanism by which the mutation-induced structural alteration of HPRT reduced the affinity of the enzyme for PRPP.

Original languageEnglish
Pages (from-to)158-161
Number of pages4
JournalMolecular Genetics and Metabolism
Volume78
Issue number2
DOIs
StatePublished - 1 Feb 2003

Keywords

  • 5-Phosphoribosyl-1-pyrophosphate
  • Hypoxanthine-guanine phosphoribosyltransferase deficiency
  • Lesch-Nyhan syndrome
  • PRPP binding motif
  • Variants of Lesch-Nyhan syndrome

Fingerprint

Dive into the research topics of 'A novel point mutation (I137T) in the conserved 5-phosphoribosyl-1-pyrophosphate binding motif of hypoxanthine-guanine phosphoribosyltransferase (HPRTJerusalem) in a variant of Lesch-Nyhan syndrome'. Together they form a unique fingerprint.

Cite this